FAM171A2: A Potential Drug Target and Biomarker for the Treatment of Human Disease

Target Name: FAM171A2

NCBI ID: G284069

FAM171A2

Other Name(s): F1712_HUMAN | Family with sequence similarity 171 member A2 | Protein FAM171A2 | family with sequence similarity 171 member A2

FAM171A2: A Potential Drug Target and Biomarker for the Treatment of Human Disease

Abstract:
FAM171A2, a gene encoding a protein known as FAM171A2, has been identified as a potential drug target and biomarker for the treatment of various human diseases. FAM171A2 has been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. This article will discuss the current state of research on FAM171A2, its potential as a drug target, and its potential as a biomarker for the diagnosis and treatment of human disease.

Introduction:
FAM171A2 is a gene that encodes a protein known as FAM171A2. The protein FAM171A2 is involved in various cellular processes that are essential for cell survival and growth. FAM171A2 has been shown to play a crucial role in the development and progression of various diseases, including cancer , neurodegenerative disorders, and autoimmune diseases.

Potential Drug Target:
FAM171A2 has been identified as a potential drug target due to its involvement in various cellular processes that are essential for cell survival and growth. Many diseases, including cancer, neurodegenerative disorders, and autoimmune diseases, are characterized by the uncontrolled growth and proliferation of cells. FAM171A2 has been shown to regulate cell growth and apoptosis, which are critical processes that help maintain the integrity of cellular order and prevent the development of cancer and other diseases.

FAM171A2 has also been shown to play a role in the regulation of cell migration and the formation of tissues. These processes are critical for the development and progression of various diseases, including cancer. Therefore, FAM171A2 may be an attractive drug target for the treatment of Diseases that are characterized by the uncontrolled growth and proliferation of cells, such as cancer.

Potential Biomarkers:
FAM171A2 has also been identified as a potential biomarker for the diagnosis and treatment of various human diseases. The reliable and sensitive detection of FAM171A2 levels in biological tissues, blood or urine can be used as an evaluation index for the diagnosis and treatment of various diseases. For example, increased levels of FAM171A2 may indicate tumor growth in the body, while decreased levels of FAM171A2 may indicate that the tumor has spread to other tissues.

In addition, FAM171A2 has also been shown to play a role in the regulation of immune cell function and the development of autoimmune diseases. Therefore, FAM171A2 may also be a useful biomarker for the diagnosis and treatment of autoimmune diseases.

Conclusion:
In conclusion, FAM171A2 is a gene that encodes a protein that plays a crucial role in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for these diseases. Further research is needed to fully understand the role of FAM171A2 in human disease and to develop effective treatments based on this protein.

Protein Name: Family With Sequence Similarity 171 Member A2

The "FAM171A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM171A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets